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INTRODUCTION
Bicuspid aortic valve (BAV) is the most common congenital 
heart valve disease, with an overall incidence of approximate-
ly 1% in the general population.1,2 Subjects with BAV often pres-
ent with aortic dilatation and may exhibit mechanical function-
al alterations in vasculatures.3,4 In addition, BAV is a highly 
heritable trait, often associated with other congenital heart 
defects or genetic syndromes.5,6
Regarding myocardial characteristics in subjects with BAV, 
most previous studies have focused on subclinical left ven-
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Purpose: The present study aimed to investigate the prevalence, characteristics, and clinical significance of concomitant specific 
cardiomyopathies in subjects with bicuspid aortic valves (BAVs).
Materials and Methods: A total of 1186 adults with BAV (850 males, mean age 56±14 years) at a single tertiary center were com-
prehensively reviewed. Left ventricular non-compaction, hypertrophic cardiomyopathy, and idiopathic dilated cardiomyopathy 
were confirmed when patients fulfilled current clinical and echocardiographic criteria. Clinical and echocardiographic charac-
teristics, including comorbidities, heart failure presentation, BAV morphology, function, and aorta phenotypes, in BAV subjects 
with or without specific cardiomyopathies were compared.
Results: Overall, 67 subjects (5.6%) had concomitant cardiomyopathies: 40 (3.4%) patients with left ventricular non-compaction, 
17 (1.4%) with hypertrophic cardiomyopathy, and 10 (0.8%) with dilated cardiomyopathy. BAV subjects with hypertrophic car-
diomyopathy had higher prevalences of diabetes mellitus and heart failure with preserved ejection fraction, and tended to have 
type 0 phenotype, while BAV subjects with dilated cardiomyopathy showed higher prevalences of chronic kidney disease and 
heart failure with reduced ejection fraction. BAV subjects with left ventricular non-compaction were significantly younger and 
predominantly male, and had greater BAV dysfunction and a higher prevalence of normal aorta shape. In multiple regression 
analysis, cardiomyopathy was independently associated with heart failure (odds ratio 2.795, 95% confidential interval 1.603–
4.873, p<0.001) after controlling for confounding factors. 
Conclusion: Concomitant cardiomyopathies were observed in 5.6% of subjects with BAV. A few different clinical and echocardio-
graphic characteristics were found. The presence of cardiomyopathy was independently associated with heart failure.
Key Words:  Bicuspid aortic valve, hypertrophic cardiomyopathy, non-compaction, dilated cardiomyopathy
Original Article 
pISSN: 0513-5796 · eISSN: 1976-2437
Received: March 25, 2019   Revised: June 28, 2019
Accepted: July 15, 2019
Corresponding author: Chi Young Shim, MD, PhD, Division of Cardiology, De-
partment of Internal Medicine, Severance Cardiovascular Hospital, Yonsei Univer-
sity College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
Tel: 82-2-2228-8453, Fax: 82-2-2227-7742, E-mail: cysprs@yuhs.ac
•The authors have no potential conflicts of interest to disclose.
© Copyright: Yonsei University College of Medicine 2019
This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution Non-Commercial License (https://creativecommons.org/licenses/
by-nc/4.0) which permits unrestricted non-commercial use, distribution, and repro-
duction in any medium, provided the original work is properly cited.
Yonsei Med J 2019 Sep;60(9):816-823
https://doi.org/10.3349/ymj.2019.60.9.816
817
Hyeonju Jeong, et al.
https://doi.org/10.3349/ymj.2019.60.9.816
tricular dysfunction associated with increased aortic stiff-
ness.7-9 Although a possible association between BAV and spe-
cific cardiomyopathies (CMs) based on common genetic traits 
has been proposed in several case reports,10,11 data on the prev-
alence of coexisting specific CMs in subjects with BAV are lim-
ited. In a previous study, an incidence of 11% for left ventricular 
non-compaction (LVNC) in 109 patients with BAV was report-
ed.12 In a recent large population study, a prevalence of only 
0.4% for hypertrophic CM (HCM) was reported in 5430 pa-
tients with BAV, similar to the general population.13 However, 
the prevalence of concomitant specific CMs might be differ-
ent based on ethnicity. Moreover, data are lacking regarding 
clinical and echocardiographic characteristics based on the 
type of concomitant CMs. Therefore, in the present study, the 
prevalence, characteristics, and clinical significance of concomi-
tant CMs, including LVNC, HCM, and idiopathic dilated CM 
(DCM), were determined using a large Korean BAV registry.
MATERIALS AND METHODS
Study population
We retrospectively reviewed subjects diagnosed with BAV us-
ing transthoracic echocardiography in Severance Cardiovas-
cular Hospital from January 2003 to December 2017. A total of 
1186 subjects (850 males, mean age 56±14 years) were includ-
ed in this study. All echocardiographic studies in subjects with 
BAV were manually reviewed for confirmation. Patient medi-
cal data as recorded by the physicians were carefully reviewed 
by two experienced observers who were blinded to echocar-
diography results. Patients who presented with acute heart fail-
ure were not included in the present study. The institutional 
review board of Severance Hospital approved the present study 
(IRB No. 2015-0403-001), which was conducted in compli-
ance with the Declaration of Helsinki. The subjects were clas-
sified into four groups based on the presence of specific CMs.  
Standard two-dimensional and Doppler measurements 
were performed following the American Society of Echocar-
diography guidelines.14 BAV was diagnosed based on anatom-
ic evaluation of the aortic valve, when only two cusps were un-
equivocally identified in systole and diastole in the short-axis 
view and with a clear “fish mouth” appearance during systo-
le.15 BAV morphology was classified into four types based on 
position and pattern of raphe and cusps: Type 1 exhibited fu-
sion of the left coronary and right coronary cusps, type 2 indi-
cated fusion of the right coronary and noncoronary cusps, and 
type 3 comprised fusion of the left coronary and noncoronary 
cusps. Type 0 was recorded when there were two developed 
cusps and no raphe (true type).15,16 The severity of aortic ste-
nosis or aortic regurgitation was assessed using integrated ap-
proaches.17,18 The dimensions of the sinus of Valsalva, sinotu-
bular junction, and ascending aorta were measured as previously 
described.7,15 The presence of aortopathy was defined as an 
ascending aorta dimension ≥40 mm, as previously defined.
HCM was clinically diagnosed based on the presence of un-
explained myocardial hypertrophy (wall thickness ≥15 mm) 
in the absence of local or systemic etiologies capable of pro-
ducing the extent of hypertrophy evident.13 Mild systemic hy-
pertension was not an exclusion criterion in the diagnosis of 
HCM. Subjects with coexisting HCM were subdivided into 
three morphologically obstructive HCM subgroups, non-ob-
structive HCM, non-apical HCM, or non-obstructive apical 
HCM, based on either the presence of left ventricular outflow 
track obstruction or the predominant hypertrophy at the left 
ventricular apex. LVNC was diagnosed based on previously 
suggested echocardiographic criteria19-21 and/or ratios between 
noncompacted and compacted layers of the left ventricular 
wall on cardiac magnetic resonance imaging.22 If the diagno-
sis of LVNC was suspected but not confirmed using echocar-
diography, cardiac magnetic resonance imaging was performed. 
DCM was defined as an ejection fraction <40% in the presence 
of increased left ventricular dimension. Subjects with ischemic 
heart disease, uncorrected or corrected severe aortic stenosis 
or aortic regurgitation, and other reversible causes were ex-
cluded from diagnosis of idiopathic DCM in this study. Echo-
cardiographic data were gathered and analyzed by experienced 
sonographers blinded to each patient’s clinical data. Heart fail-
ure was diagnosed using current diagnostic criteria23 and was 
categorized based on left ventricular ejection fraction (LVEF) 
as follows: heart failure with preserved ejection fraction (LVEF 
≥50%) and heart failure with reduced ejection fraction (LVEF 
<50%).
Continuous variables are expressed as a mean±standard de-
viation. Categorical variables are expressed as a number (per-
centage). Comparisons between groups were performed us-
ing standard λ2 tests for categorical variables and paired t-tests 
for continuous variables. Univariate and multivariate logistic 
regression analyses were performed. All statistical analyses 
were performed using SPSS Statistics, version 23.0 (IBM, Ar-
monk, NY, USA). p values <0.05 were considered statistically 
significant.
RESULTS
Prevalence of coexistent CMs in BAV subjects 
Overall, 67 subjects (5.6%) had concomitant CMs: 10 (0.8%) 
subjects with DCM, 17 (1.4%) with HCM, and 40 (3.4%) with 
LVNC. Among the subjects with coexistent HCM, five had ob-
structive HCM, six presented with non-obstructive HCM, and 
six with apical HCM (Fig. 1).
Characteristics of BAV subjects with HCM, LVNC, or 
DCM
Baseline characteristics of the subjects with or without specif-
ic CMs are shown in Table 1. Subjects with DCM had a higher 
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prevalence of chronic kidney disease and heart failure with 
reduced ejection fraction, compared with those without CM. 
Subjects with HCM showed higher prevalences of diabetes 
mellitus and heart failure with preserved ejection fraction than 
those without CM. Subjects with LVNC were younger and pre-
dominantly male, compared with those without CM. In addi-
tion, subjects with LVNC exhibited a lower prevalence of heart 
failure than patients with DCM or HCM. 
Table 2 shows the structural and functional characteristics 
of the left ventricle in each group. The echocardiographic vari-
ables, including left ventricle dimension, wall thickness, and 
LVEF, were significantly different among the groups because 
of their own disease characteristics. LA volume index values 
in BAV subgroups with specific CMs were significantly greater 
than those in the BAV group without CMs. Early diastolic mi-
tral annular tissue (e’) velocity and ratio of early diastolic mi-
tral inflow velocity to e’ velocity (E/e’) in BAV subgroups with 
HCM and DCM were also significantly greater than those in 
BAV subgroups without CMs. However, right ventricular systol-
ic pressure was not significantly different among the groups.
The BAV characteristics in Table 3 and Fig. 2 show that the 
type 1 BAV phenotype (fusion of right and left coronary cusps) 
was the most prevalent morphology in all groups. Although 
subjects with HCM tended to have type 0 phenotype, there was 
no statistically significant differences in BAV phenotypes among 
the groups. Subjects with DCM comprised a higher prevalence 
of no or mild dysfunction, while subjects with LVNC exhibited 
a lower prevalence of no or mild dysfunction. Regarding aorta 
Table 1. Baseline Characteristics according to the Presence of Specific Cardiomyopathy
No CM (n=1119) DCM (n=10) HCM (n=17) LVNC (n=40) p value
Age (yr) 56±15 56±5 60±13 51±16*‡ 0.097
Male 793 (71) 8 (80) 13 (77) 35 (88)* 0.135
Body mass index (kg/m2) 23.9±3.6 23.7±3.5 24.7±2.2 23.4±3.2 0.666
Hypertension 462 (41) 3 (30) 10 (59) 17 (43) 0.444
Diabetes mellitus 209 (19) 3 (30) 9 (52)* 4 (10)‡ 0.001
Dyslipidemia 231 (21) 1 (10) 3 (18) 10 (25) 0.742
CAD 182 (16) 0 (0) 2 (12) 5 (13) 0.464
CKD 97 (9) 3 (30)* 2 (12) 4 (10) 0.124
Heart failure 178 (16) 6 (60)* 8 (47) 8 (20)†‡ <0.001
Preserved EF 129 (12) 0 (0) 8 (47)*† 6 (15)‡ <0.001
Reduced EF 49 (4) 6 (60)* 0 (0)† 2 (5)† <0.001
CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction; CAD, coronary artery disease; 
CKD, chronic kidney disease; EF, ejection fraction.
Values are presented as mean±standard deviation or n (%) unless otherwise indicated.
*p<0.05 compared to the group with no CM; †p<0.05 compared to the DCM group; ‡p<0.05 compared to the HCM group.
BAV subjects (n=1186)
BAV with CM (n=67, 5.6%) Obstructive
(n=5, 7.4%)
Non-obstructive
(n=6, 9.0%)
Apical
(n=6, 9.0%)
BAV without CM
(n=1119, 94.4%) LVNC
(n=40, 59.7%)
HCM
(n=17, 25.4%)
DCM
(n=10, 14.9%)
DCM (n=10, 0.8%)
LVNC (n=40, 3.4%)
HCM (n=17, 1.4%)
BAV subjects with CM (n=67)
A B
DCM
HCM
LVNC
DCM
HCM
LVNC
Fig. 1. Prevalence of specific cardiomyopathies in bicuspid aortic valves (BAV) subjects. (A) A total of 1186 BAV subjects. (B) Sixty-seven BAV subjects 
with cardiomyopathy (CM). LVNC, left ventricular non-compaction; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy.
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phenotypes, subjects with LVNC revealed a higher prevalence 
of normal shape than those without CMs. Although statistical 
significance was not observed, more DCM patients had pre-
dominant AA phenotype, and none showed predominant si-
nus of Valsalva. Fig. 3 illustrates the representative cases of co-
existing CMs in subjects with BAV.
Clinical significance of concomitant CMs in BAV 
Logistic regression analysis was performed to investigate fac-
tors associated with heart failure in subjects with BAV. In uni-
variate analysis, increased age was significantly associated with 
heart failure [odds ratio (OR) 1.035, p<0.001], while gender was 
not. Comorbidities, such as hypertension (OR 1.793, p<0.001), 
diabetes mellitus (OR 1.704, p=0.003), and chronic kidney dis-
ease (OR 2.226, p<0.001), were significantly associated with 
heart failure. Aortic valve dysfunction was not a significant as-
sociating factor for heart failure. However, an increased aorta 
diameter (OR 1.020, p=0.046) was significantly associated 
with heart failure. Moreover, presence of CM was the strongest 
factor associated with heart failure (OR 2.582, p<0.001). In mul-
tivariate analysis, age, hypertension, chronic kidney disease, 
and presence of concomitant CM were independently associ-
Table 2. Left Ventricle Characteristics according to the Presence of Specific Cardiomyopathy
No CM (n=1119) DCM (n=10) HCM (n=17) LVNC (n=40) p value
LVEDD (mm) 53.5±9.1 68.7±10.3* 50.7±9.9† 59.0±10.2*†‡ <0.001
LVESD (mm) 36.3±8.7 59.2±9.8* 31.9±8.1*† 41.9±9.5*†‡ <0.001
IVS thickness (mm) 10.7±2.2 10.1±2.6 14.7±4.2*† 10.7±2.3‡ <0.001
PW thickness (mm) 10.5±2.0 10.3±2.2 12.2±2.3*† 10.7±2.0‡ 0.005
LV ejection fraction (%) 63±12 29±11* 70±8*† 58±12*†‡ <0.001
LA volume index (mL/m2) 32.0±16.4 46.9±21.4* 36.0±14.4 37.7±16.4* 0.004
e’ velocity (cm/s) 6.1±2.5 3.5±1.4* 4.1±1.6* 6.7±3.0†‡ <0.001
E/e’ 13.0±5.9 20.0±6.6* 17.5±7.3* 12.8±5.4†‡ <0.001
RVSP (mm Hg) 29±11 33±12 25±5 29±10 0.526
CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction; LVEDD, left ventricular end-dia-
stolic dimension; LVESD, left ventricular end-systolic dimension; IVS, interventricular septum; PW, posterior wall; LV, left ventricle; LA, left atrium; e’, early dia-
stolic mitral annular tissue; E/e’, ratio of early diastolic mitral inflow velocity to early diastolic mitral annular tissue velocity; RVSP, right ventricular systolic pres-
sure.
Values are presented as mean±standard deviation unless otherwise indicated.
*p<0.05 compared to the group with no CM; †p<0.05 compared to the DCM group; ‡p<0.05 compared to the HCM group.
Table 3. BAV and Aorta Characteristics according to the Presence of Specific Cardiomyopathy
No CM (n=1119) DCM (n=10) HCM (n=17) LVNC (n=40) p value
BAV phenotypes
Type 1 (RCC+LCC) 713 (64) 7 (70) 10 (56) 26 (65) 0.934
Type 2 (RCC+NCC) 192 (17) 1 (10) 2 (11) 8 (20) 0.939
Type 3 (LCC+NCC) 62 (6) 1 (10) 0 (0) 2 (5) 0.653
Type 0 (True) 150 (13) 1 (10) 6 (30) 4 (10) 0.725
BAV dysfunction
No or mild dysfunction 383 (34) 6 (60)† 5 (28) 7 (18)*† 0.048
Significant AS 481 (43) 3 (30) 9 (53) 23 (58) 0.080
Significant AR 354 (32) 2 (20) 6 (35) 16 (40) 0.308
AV area by C.E. (cm2) 1.60±0.35 1.69±0.34 1.50±0.35 1.57±0.36 0.249
AV peak gradient (mm Hg) 13.6±8.4 11.9±7.3 18.5±9.5 17.1±8.7 0.169
Aorta phenotypes
Normal shape 388 (35) 2 (20) 6 (3) 20 (50)* 0.106
Predominant Valsalva sinus 162 (15) 0 (0) 4 (24) 4 (10) 0.597
Predominant AA 536 (48) 7 (70) 8 (47) 16 (40) 0.414
Presence of aortopathy 473 (42) 5 (50) 10 (59) 16 (40) 0.808
AA diameter (mm) 38.2±7.7 39.3±6.1 38.9±8.3 37.6±9.4 0.621
BAV, bicuspid aortic valve; CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular noncompaction; RCC, 
right coronary cusp; LCC, left coronary cusp; NCC, non-coronary cusp; AS, aortic stenosis; AR, aortic regurgitation; AV, aortic valve; C.E., continuity equation; AA, 
ascending aorta.
Values are presented as mean±standard deviation or n (%) unless otherwise indicated.
*p<0.05 compared to the group with no CM; †p<0.05 compared to the DCM group.
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Fig. 2. (A) Bicuspid aortic valves (BAV) phenotypes according to the presence of specific cardiomyopathies (CMs). (B) Aorta phenotypes according to the 
presence of specific CMs. DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction.
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Fig. 3. Representative cases of coexisting cardiomyopathies in bicuspid aortic valves subjects. (A) Hypertrophic cardiomyopathy, (B) left ventricular non-
compaction, and (C) dilated cardiomyopathy. 
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ated with heart failure (Table 4). Neither the presence of aor-
topathy nor increased aorta diameter was independently as-
sociated with heart failure in multivariate analysis.  
DISCUSSION
The principal findings of the present study are as follows. First, 
approximately 6% of BAV subjects had concomitant CMs. LVNC 
was the most prevalent; however, its prevalence in BAV sub-
jects was only 3.4% lower than that previously reported. Sec-
ond, BAV subjects with specific CMs had distinct clinical and 
echocardiographic features. Third, age, hypertension, and pres-
ence of CM were significantly associated with heart failure. To 
the best of our knowledge, this is the first study in which the 
prevalence, characteristics, and clinical implications of con-
comitant specific CMs were identified in adults with BAV using 
data from a large Korean registry. 
Case reports of specific CMs in BAV subjects have been spo-
radic, and studies on their prevalences are limited. Agarwal, 
et al.12 reported the incidence of LVNC in patients with BAV. In 
their retrospective observational study, 12 of 109 BAV patients 
(11.0%) were diagnosed with LVNC based on echocardiograph-
ic criteria. The mean age at diagnosis was 33±17 years. The in-
cidence was greater and mean age at diagnosis was signifi-
cantly lower values thereof than in our study. Chandra, et al.24 
researched the incidence of LVNC in Caucasians and African-
Americans, but not Asians, and revealed inter-racial differenc-
es in the frequency thereof in BAV patients. Therefore, the dif-
ferences in incidences between the present study and Agarwal, 
et al.12 may likely be due to population characteristics, includ-
ing age and race. Padang, et al.13 reported the incidence of HCM 
in patients with BAV. In their retrospective cohort, 23 patients 
were diagnosed with HCM and BAV based on echocardio-
graphic criteria. The mean age at diagnosis was 52±16 years. 
Their study showed 0.9% of patients with HCM had coexistent 
BAV and 0.4% of patients with BAV had coexistent HCM. The 
incidence of BAV in the general population is usually approxi-
mately 1%; therefore, the incidence of BAV was not deemed dif-
ferent between HCM and general populations. In our study, 
1.4% of patients had concomitant BAV and HCM, and these 
results are similar to a previous study.13 In the present study, id-
iopathic DCM was identified in 0.8% of BAV subjects, similar 
to the results found in the general population. To date, studies 
on the prevalence of DCM in BAV subjects have not been pub-
lished, probably because a certain degree of aortic valve dysfunc-
tion can result in chamber dilatation and myocardial dysfunc-
tion. To eliminate confounding factors, patients with significant 
aortic valve dysfunction were excluded when diagnosing idio-
pathic DCM. Therefore, the actual prevalence of coexisting DCM 
in BAV subjects might be underestimated in this study. In a pre-
vious study, genetic factors were suggested as a possible cause 
of coexistent BAV and HCM.25 However, few studies exist on 
genes in patients with BAV and specific CMs. In the future, ge-
netic analysis will be important in studying the relationship be-
tween BAV and CM.
Recently, research into BAV has focused not only in the valve 
itself, but also in relation to the left ventricle and aorta.7-9 Since 
BAV patients with concomitant CMs have prominent charac-
teristics of their own myocardial disease, there were no signif-
icantly different characteristics in BAV morphology, aortic valve 
dysfunction, or aorta phenotype in overall group comparison. 
Although type 0 BAV phenotype and presence of aortopathy 
tended to be more prevalent in BAV patients with HCM, these 
tendencies did not show statistical significance. 
Predictably, the presence of specific CMs may influence a 
patient’s clinical course, especially in regards to heart failure 
in BAV subjects. Heart failure was associated with 16.9% of all 
BAV subjects and 32.8% of BAV subjects with specific CMs. In 
univariate analysis, age and well-known comorbidities were 
correlated with heart failure, as expected. Regarding several 
specific characteristics in BAV subjects, increased aortic di-
ameter was positively associated with heart failure, while sig-
nificant aortic valve dysfunction was not. These findings sup-
port a possible ventricular vascular interaction in BAV subjects, 
which has been suggested in previous studies.3,7-9 However, the 
Table 4. Factors associated with Heart Failure in BAV Subjects
Variable
Univariate Multivariate
OR 95% CI p value OR 95% CI p value
Age 1.035 1.002–1.047 <0.001 1.029 1.016–1.042 <0.001
Female 1.164 0.835–1.623 0.370 1.167 0.924–1.651 0.384
Body mass index 1.027 0.986–1.069 0.197 1.025 0.981–1.072 0.273
Hypertension 1.793 1.320–2.435 <0.001 1.436 1.034–1.195 0.031
Diabetes mellitus 1.704 1.196–2.429 0.003 1.171 0.798–1.179 0.419
CKD 2.226 1.420–3.489 <0.001 1.635 1.013–2.038 0.044
Significant AS or AR 0.958 0.691–1.327 0.795 0.960 0.684–1.348 0.815
Aortopathy 1.320 0.973–1.790 0.074 1.194 0.795–1.508 0.581
Aorta diameter 1.020 1.000–1.040 0.046 - - -
CM 2.582 1.513–4.406 0.001 2.795 1.603–4.873 <0.001
BAV, bicuspid aortic valve; OR, odds ratio; CI, confidence interval; CKD, chronic kidney disease; AS, aortic stenosis; AR, aortic regurgitation; CM, cardiomyopathy.
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strongest factor associated with heart failure was the presence 
of CM. Consequently, in multivariate analysis, age, hyperten-
sion, and presence of CM were independently associated with 
heart failure. 
The present study had several limitations. First, this study 
included only Korean BAV subjects from a single tertiary re-
ferral center, which may result in bias. Therefore, multinational 
studies including various ethnic groups are needed to evaluate 
the prevalence of CMs in BAV subjects. However, we believe 
this study was the first to report on the prevalence of concom-
itant CMs in a large Korean registry using comprehensive re-
views. Second, data were lacking regarding common genetic 
backgrounds in BAV patients with CMs. The results of this study 
may be a basis for future genetic research. Third, chronic he-
modynamic effects of significant AS resulting in acquired LV 
hypertrophy or noncompaction cannot be fully excluded, al-
though patients with severe AS were not included in this study. 
Forth, aortic diameters were measured based on echocardio-
graphic imaging alone because only some BAV subjects under-
went computed tomography or cardiac magnetic resonance 
imaging.
In conclusion, concomitant BAV with CMs was observed in 
5.6% of our BAV population. Several clinical and echocardio-
graphic characteristics, including comorbidities, heart failure 
presentation, BAV phenotypes, valve function, and presence 
of aortopathy were found in these patients. The presence of 
CM was independently associated with heart failure.
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